Home

BioHarvest Sciences Inc. - Common Stock (BHST)

7.9750
+0.6440 (8.78%)
NASDAQ · Last Trade: Sep 12th, 10:07 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Earnings Scheduled For August 11, 2025benzinga.com
Via Benzinga · August 11, 2025
Earnings Scheduled For May 15, 2025benzinga.com
Via Benzinga · May 15, 2025
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cellsbenzinga.com
BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
Via Benzinga · March 4, 2025
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Moleculesbenzinga.com
Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.
Via Benzinga · December 11, 2024